主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BGLC
#8992
BioNexus Gene Lab Corp Common stock
2.265
0
USD
-2.37%
版块:
基础材料
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-2.37%
每月变动
+0.89%
6个月变化
+0.89%
年变化
+0.89%
前一天收盘价
2.320
0
Open
2.236
0
Bid
2.265
0
Ask
2.268
0
Low
2.230
0
High
2.299
9
交易量
7
市场
股票
基础材料
BGLC
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
1.8 M
17.97 M
1.8 M
1.8 M
1.8 M
—
Valuation ratios
Enterprise value
—
—
—
5.52 M
9.83 M
—
Price to earnings ratio
—
—
—
—
-24.75
—
Price to sales ratio
—
—
—
—
1.86
—
Price to cash flow ratio
—
—
—
—
-4.79
—
Price to book ratio
—
—
—
—
0.62
—
Enterprise value to EBITDA ratio
—
—
—
0.86
1.85
—
Profitability ratios
Return on assets %
-0.12
-0.03
-0.07
-0.07
-0.09
-0.26
Return on equity %
-0.14
-0.04
-0.08
-0.08
-0.1
-0.31
Return on invested capital %
-67.8
-19.74
-34
—
—
—
Gross margin %
12.41
12.25
16.07
16.28
14.85
59.45
Operating margin %
-50.85
-16.49
-28.94
-27.05
-27.62
-100.09
EBITDA margin %
-67.25
298.41
68.48
-35.08
-113.53
218.28
Net margin %
-51.15
-13.8
-29.17
-27.26
-27.87
-98.1
Liquidity ratios
Quick ratio
3.99
3.1
3.44
2.94
6.81
16.28
Current ratio
4.98
3.81
4.19
3.63
8.3
19.93
Inventory turnover
—
0.03
0.01
0.01
0.02
0.08
Asset turnover
0.24
0.24
0.21
0.24
0.3
0.99
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
0
-0.05
-0.41
-0.69
-1.14
EBIT per share
—
0.42
0.08
-0.46
-0.45
-0.41
EBITDA per share
—
0.42
0.08
-0.44
-1.61
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.09
0.06
—
—
—
Net current asset value per share
—
0.42
0.36
3.55
3.13
7.46
Tangible book value per share
—
0.47
0.43
4.19
3.79
8.88
Working capital per share
—
0.31
0.28
2.57
2.75
5.91
Book value per share
—
0.47
0.43
4.19
3.79
8.88
新闻
BioNexus Gene Lab任命Fidelion首席商务官
BioNexus Gene Lab appoints commercial officer at Fidelion
BioNexus Gene Lab完成与Fidelion Diagnostics的战略交易
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics
BioNexus Gene Lab股价在获得5亿美元股权融资后下跌
BioNexus Gene Lab stock falls after securing $500M equity facility
BioNexus Gene Lab secures $500 million equity purchase agreement
BioNexus Gene Lab股价在获得5亿美元股权融资后上涨
BioNexus Gene Lab stock climbs after securing $500 million equity facility
BioNexus Gene Lab股价在达成MRD检测战略协议后飙升
BioNexus Gene Lab与合作伙伴达成协议商业化液体活检平台
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform